Company: BDRX
Filing Date: 2025-06-13
Form Type: 424B3
Source: 0001214659-25-009218
Chunk: 89

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-06-13
Form: 424B3
Chunk 89
---
 1 penny   
 for all the C Deferred Shares so purchased. If such a resolution is passed and the Company is in all other respects able and willing to      
 purchase the C Deferred Shares to which the contract relates in accordance with Sections 690 to 708 of the Act, the Company shall have       
 irrevocable authority to appoint any person: (i) to execute such contract on behalf of each of the holders of the relevant C Deferred        
 Shares; (ii) to execute a stock transfer form (or forms) sufficient in every respect to transfer to the Company the legal title to the       
 C Deferred Shares that are the subject of such contract, and (iii) to receive at completion the purchase price on behalf of the holders      
 of the C Deferred Shares. From the time that such resolution is passed, the holders of the C Deferred Shares that are the subject of such    
 contract shall hold such shares as bare trustee for the Company.                                                                             |

| 70 |

| 145.3 | -A | Subject to the Act, the Company may, at its option, cancel C Deferred Shares by way of a reduction 
 of capital for no consideration; and/or                                                            |

| (B) | Pending any such transfer and/or purchase and/or cancellation, the Company may              
 retain any share certificate that may be issued in respect of any of the C Deferred Shares. |

| 146 | D DEFERRED SHARES |

| 146.1 | The following rights and restrictions shall be attached to the D Deferred Shares of £0.000001 each: |

| (A) | As             
 regards income |

The holders of the D Deferred Shares
shall not be entitled to receive any dividend or any other distribution out of the profits of the Company including, without limitation,
any allotment (whether or not fully paid) as a result of the capitalisation of any sum standing to the credit of any share premium account
or of any reserve (whether or not available for distribution) of the Company;

| (B) | As regards voting |

The holders of the D Deferred Shares
shall not be entitled to receive notice of or to attend or speak (either personally or by proxy) at any general meeting of the Company
or to vote (either personally or by proxy) on any resolution to be proposed at any general meeting of the Company and shall be deemed
by virtue of the passing of the resolution adopting these Articles to have irrevocably agreed to any purchase, cancellation and extinguishment
of the D Deferred Shares pursuant to Articles 146